GlassScriptPhysician profile
Sameer M Naranje
NPI 1891098851
$11,781.00
in general payments reported to CMS, 2019-2025
23 companies · $72.33 in 2025
The $72.33 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,469 · 2020: $450 · 2021: $984 · 2022: $2,856 · 2023: $1,431 · 2024: $518 · 2025: $72.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,069.23 | 2019-2023 | Real Intelligence, Journey II, Or3o Dual Mobility |
| Omnilife Science, INC | $2,031.63 | 2019-2024 | Various Products, Omnibotics 3.0 |
| Zimmer Biomet Holdings, INC. | $1,711.03 | 2019-2025 | |
| Medacta USA, INC. | $1,474.48 | 2022-2024 | Gmk Sphere, Gmk Efficiency |
| Depuy Synthes Sales INC. | $674.41 | 2021-2023 | |
| Corin USA | $598.96 | 2019 | |
| Sanara Medtech INC. | $400.83 | 2021-2022 | |
| Stryker Corporation | $378.60 | 2019-2023 | Augment Injectable, Mako |
| Biom'Up Sa | $257.56 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Amgen INC. | $121.83 | 2019 | |
| Pacira Therapeutics, INC. | $121.83 | 2020 | |
| Onkos Surgical, INC. | $113.99 | 2019-2020 | |
| Biocomposites INC | $113.79 | 2023 | Stimulan |
| Abbott Laboratories | $106.66 | 2023 | Mitraclip |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $100.73 | 2021 | |
| Alexion Pharmaceuticals, INC. | $100.00 | 2019 | |
| Xeris Pharmaceuticals, INC. | $88.06 | 2023 | Gvoke Hypopen |
| Heraeus Medical, LLC. | $85.24 | 2020-2022 | |
| Illuminoss Medical, INC. | $64.12 | 2024 | |
| Medical Device Business Services, INC. | $28.99 | 2022 | |
| Integra Lifesciences Corporation | $14.03 | 2024 | Tenoglide |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Naranje listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.